4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-000865
Chief Medical Officer sold 8,303 shares at an average $35.26 ($292,804)
- Chief Medical Officer acquired 75,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
San Martin Javier · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-04 | Grant or award : show line 1 in the form 10b5-1 | +75,000 | 206,800 | D | ||
| 2024-01-05 | Sale : show line 2 in the form 10b5-1 | −800 | $34.11 | $27,288 | 206,000 | D |
| 2024-01-05 | Sale : show line 3 in the form 10b5-1 | −3,100 | $35.03 | $108,593 | 202,900 | D |
| 2024-01-05 | Sale : show line 4 in the form 10b5-1 | −4,403 | $35.64 | $156,923 | 198,497 | D |
| Open-market sales · 8,303 sh · avg $35.26 · $292,804 | ||||||
Loading xslF345X05/wk-form4_1704752165.xml…